{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "3533122",
  "DateCompleted": {
    "Year": "1986",
    "Month": "12",
    "Day": "02"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0306-5251",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "3",
        "PubDate": {
          "Year": "1986",
          "Month": "Sep"
        }
      },
      "Title": "British journal of clinical pharmacology",
      "ISOAbbreviation": "Br J Clin Pharmacol"
    },
    "ArticleTitle": "States of anxiety and their induction by drugs.",
    "Pagination": {
      "StartPage": "251",
      "EndPage": "261",
      "MedlinePgn": "251-61"
    },
    "Abstract": {
      "AbstractText": [
        "Syndromes of anxiety include generalized anxiety states, various forms of phobic disorder and panic attacks. It is unclear whether panic attacks are a separate syndrome from anxiety states or a more severe form. Drug-induced states of anxiety should provide useful models of the mechanisms of anxiety and its treatment. High-risk populations might be identifiable. Catecholamine infusions produce marked peripheral changes without fully reproducing the central feelings. Lactate infusions also produce anxiety-like states lacking full credibility. Experience with the benzodiazepine-receptor contragonists, the beta-carbolines, is limited but panic states have been reproduced following their use. Caffeine produces an anxiety state in high dose and some panic states have been induced. The critical evaluation of drug-induced anxiety states is a promising way of elucidating the mechanisms, psychological and physiological, associated with clinical anxiety."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lader",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bruce",
        "ForeName": "M",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Clin Pharmacol",
    "NlmUniqueID": "7503323",
    "ISSNLinking": "0306-5251"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Carbolines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lactates"
    },
    {
      "RegistryNumber": "2Y49VWD90Q",
      "NameOfSubstance": "Yohimbine"
    },
    {
      "RegistryNumber": "3G6A5W338E",
      "NameOfSubstance": "Caffeine"
    },
    {
      "RegistryNumber": "YKH834O4BH",
      "NameOfSubstance": "Epinephrine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "chemically induced",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Caffeine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Carbolines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epinephrine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lactates"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Psychological"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Yohimbine"
    }
  ]
}